Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The Monoclonal Antibody therapy refers to a form of immunotherapy that uses monoclonal antibodies (mAb) to bind mono specifically to certain cells or proteins. Monoclonal antibodies are being used to treat severe and chronic diseases such as rheumatoid arthritis, Crohn's disease, psoriasis, osteoporosis, systemic lupus erythematosus and certain types of cancer.
Increasing focus on biomedical, stem cell and cancer research is a key factor contributing to the dominant market share in North America. The global Monoclonal Antibody Therapeutics market size is expected to gain growth in the forecast period of 2020 to 2026, with a CAGR of 6.9% and will expected to reach USD 146521 million by 2026.
The increasing use of monoclonal antibody therapy in the treatment of cancer and autoimmune diseases is a factor that promotes the market development of Monoclonal Antibody Therapeutics. Besides, increased funding from government agencies for proteomics and genomics research is another factor expected to contribute to market growth during the forecast period. However, factors such as high costs and stringent government regulations will limit market growth over the forecast period.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Monoclonal Antibody Therapeutics market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Monoclonal Antibody Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Monoclonal Antibody Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
AbbVie
Pfizer
Bayer
Roche
Sanofi
GlaxoSmithKline
Novartis
Merck
By Type:
Humanized Antibody
Human Mouse Chimeric Antibody
By End-User:
Hospitals
Clinics
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Monoclonal Antibody Therapeutics Market
-
1.3 Market Segment by Type
-
1.3.1 USA Monoclonal Antibody Therapeutics Market Size and Growth Rate of Humanized Antibody from 2016 to 2027
-
1.3.2 USA Monoclonal Antibody Therapeutics Market Size and Growth Rate of Human Mouse Chimeric Antibody from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Monoclonal Antibody Therapeutics Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 USA Monoclonal Antibody Therapeutics Market Size and Growth Rate of Clinics from 2016 to 2027
-
1.4.3 USA Monoclonal Antibody Therapeutics Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Monoclonal Antibody Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Monoclonal Antibody Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Monoclonal Antibody Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Monoclonal Antibody Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Monoclonal Antibody Therapeutics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Monoclonal Antibody Therapeutics by Major Types
-
3.4.1 Market Size and Growth Rate of Humanized Antibody
-
3.4.2 Market Size and Growth Rate of Human Mouse Chimeric Antibody
4 Segmentation of Monoclonal Antibody Therapeutics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Monoclonal Antibody Therapeutics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Monoclonal Antibody Therapeutics in Hospitals
-
4.4.2 Market Size and Growth Rate of Monoclonal Antibody Therapeutics in Clinics
-
4.4.3 Market Size and Growth Rate of Monoclonal Antibody Therapeutics in Others
5 Market Analysis by Regions
-
5.1 USA Monoclonal Antibody Therapeutics Production Analysis by Regions
-
5.2 USA Monoclonal Antibody Therapeutics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Monoclonal Antibody Therapeutics Landscape Analysis
-
6.1 West USA Monoclonal Antibody Therapeutics Landscape Analysis by Major Types
-
6.2 West USA Monoclonal Antibody Therapeutics Landscape Analysis by Major End-Users
7 South USA Monoclonal Antibody Therapeutics Landscape Analysis
-
7.1 South USA Monoclonal Antibody Therapeutics Landscape Analysis by Major Types
-
7.2 South USA Monoclonal Antibody Therapeutics Landscape Analysis by Major End-Users
8 Middle West USA Monoclonal Antibody Therapeutics Landscape Analysis
-
8.1 Middle West USA Monoclonal Antibody Therapeutics Landscape Analysis by Major Types
-
8.2 Middle West USA Monoclonal Antibody Therapeutics Landscape Analysis by Major End-Users
9 Northeast USA Monoclonal Antibody Therapeutics Landscape Analysis
-
9.1 Northeast USA Monoclonal Antibody Therapeutics Landscape Analysis by Major Types
-
9.2 Northeast USA Monoclonal Antibody Therapeutics Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 AbbVie
-
10.1.1 AbbVie Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Pfizer
-
10.2.1 Pfizer Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Bayer
-
10.3.1 Bayer Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Roche
-
10.4.1 Roche Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Sanofi
-
10.5.1 Sanofi Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 GlaxoSmithKline
-
10.6.1 GlaxoSmithKline Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Novartis
-
10.7.1 Novartis Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Merck
-
10.8.1 Merck Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Monoclonal Antibody Therapeutics Market Size and Growth Rate of Humanized Antibody from 2016 to 2027
-
Figure USA Monoclonal Antibody Therapeutics Market Size and Growth Rate of Human Mouse Chimeric Antibody from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Monoclonal Antibody Therapeutics Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure USA Monoclonal Antibody Therapeutics Market Size and Growth Rate of Clinics from 2016 to 2027
-
Figure USA Monoclonal Antibody Therapeutics Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Monoclonal Antibody Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Monoclonal Antibody Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Monoclonal Antibody Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Monoclonal Antibody Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Monoclonal Antibody Therapeutics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Monoclonal Antibody Therapeutics
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Monoclonal Antibody Therapeutics by Different Types from 2016 to 2027
-
Table Consumption Share of Monoclonal Antibody Therapeutics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Humanized Antibody
-
Figure Market Size and Growth Rate of Human Mouse Chimeric Antibody
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Monoclonal Antibody Therapeutics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Monoclonal Antibody Therapeutics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Clinics
-
Figure Market Size and Growth Rate of Others
-
Table USA Monoclonal Antibody Therapeutics Production by Regions
-
Table USA Monoclonal Antibody Therapeutics Production Share by Regions
-
Figure USA Monoclonal Antibody Therapeutics Production Share by Regions in 2016
-
Figure USA Monoclonal Antibody Therapeutics Production Share by Regions in 2021
-
Figure USA Monoclonal Antibody Therapeutics Production Share by Regions in 2027
-
Table USA Monoclonal Antibody Therapeutics Consumption by Regions
-
Table USA Monoclonal Antibody Therapeutics Consumption Share by Regions
-
Figure USA Monoclonal Antibody Therapeutics Consumption Share by Regions in 2016
-
Figure USA Monoclonal Antibody Therapeutics Consumption Share by Regions in 2021
-
Figure USA Monoclonal Antibody Therapeutics Consumption Share by Regions in 2027
-
Table West USA Monoclonal Antibody Therapeutics Consumption by Types from 2016 to 2027
-
Table West USA Monoclonal Antibody Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure West USA Monoclonal Antibody Therapeutics Consumption Share by Types in 2016
-
Figure West USA Monoclonal Antibody Therapeutics Consumption Share by Types in 2021
-
Figure West USA Monoclonal Antibody Therapeutics Consumption Share by Types in 2027
-
Table West USA Monoclonal Antibody Therapeutics Consumption by End-Users from 2016 to 2027
-
Table West USA Monoclonal Antibody Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2016
-
Figure West USA Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2021
-
Figure West USA Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2027
-
Table South USA Monoclonal Antibody Therapeutics Consumption by Types from 2016 to 2027
-
Table South USA Monoclonal Antibody Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure South USA Monoclonal Antibody Therapeutics Consumption Share by Types in 2016
-
Figure South USA Monoclonal Antibody Therapeutics Consumption Share by Types in 2021
-
Figure South USA Monoclonal Antibody Therapeutics Consumption Share by Types in 2027
-
Table South USA Monoclonal Antibody Therapeutics Consumption by End-Users from 2016 to 2027
-
Table South USA Monoclonal Antibody Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2016
-
Figure South USA Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2021
-
Figure South USA Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2027
-
Table Middle West USA Monoclonal Antibody Therapeutics Consumption by Types from 2016 to 2027
-
Table Middle West USA Monoclonal Antibody Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Monoclonal Antibody Therapeutics Consumption Share by Types in 2016
-
Figure Middle West USA Monoclonal Antibody Therapeutics Consumption Share by Types in 2021
-
Figure Middle West USA Monoclonal Antibody Therapeutics Consumption Share by Types in 2027
-
Table Middle West USA Monoclonal Antibody Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Monoclonal Antibody Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2016
-
Figure Middle West USA Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2021
-
Figure Middle West USA Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2027
-
Table Northeast USA Monoclonal Antibody Therapeutics Consumption by Types from 2016 to 2027
-
Table Northeast USA Monoclonal Antibody Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Monoclonal Antibody Therapeutics Consumption Share by Types in 2016
-
Figure Northeast USA Monoclonal Antibody Therapeutics Consumption Share by Types in 2021
-
Figure Northeast USA Monoclonal Antibody Therapeutics Consumption Share by Types in 2027
-
Table Northeast USA Monoclonal Antibody Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Monoclonal Antibody Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2016
-
Figure Northeast USA Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2021
-
Figure Northeast USA Monoclonal Antibody Therapeutics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of AbbVie
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
-
Figure Sales and Growth Rate Analysis of AbbVie
-
Figure Revenue and Market Share Analysis of AbbVie
-
Table Product and Service Introduction of AbbVie
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
